NDC 31722-021 – Divalproex sodium
Divalproex Sodium 250 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC31722-021
Product details
- Brand name
- Divalproex sodium
- Generic name
- Divalproex sodium
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA215527
- Marketed since
- September 23, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Active ingredients
- Divalproex Sodium 250 mg/1
Uses, dosage, side effects and warnings for Divalproex Sodium →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 31722-021-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-021-01) | Sep 26, 2023 |
| 31722-021-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-021-05) | Sep 26, 2023 |
Other Divalproex Sodium products
- 50090-7763 Divalproex Sodium 250 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-2007 Divalproex Sodium 250 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-4737 Divalproex Sodium 500 mg/1 · Tablet, Film Coated, Extended Release · A-S Medication Solutions
- 50090-7635 Divalproex Sodium 125 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-7841 Divalproex Sodium 500 mg/1 · Tablet, Film Coated, Extended Release · A-S Medication Solutions
- 50090-4861 Divalproex Sodium 125 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-1123 Divalproex Sodium 250 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-7121 Divalproex Sodium 125 mg/1 · Tablet, Delayed Release · A-S Medication Solutions
- 50090-6074 Divalproex Sodium 500 mg/1 · Tablet, Film Coated, Extended Release · A-S Medication Solutions
- 27241-115 Divalproex Sodium 125 mg/1 · Capsule, Coated Pellets · Ajanta Pharma USA Inc.
- 62332-821 Divalproex Sodium 125 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Inc.
- 46708-821 Divalproex Sodium 125 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Limited